Product Evaluation Study: CX-Clear Vaginal Suppositories for Cervical HPV Clearance

The Challenge of Cervical HPV

A persistent high-risk Human Papillomavirus (HPV) infection in the cervix is the primary cause of cervical cancer. While the immune system naturally clears approximately 90% of these infections within two years, high-risk strains (such as HPV 16 and 18) can linger. Over 15 to 20 years, these persistent strains can cause cellular changes that progress into cancer.

The Current Standard: "Watchful Waiting"
While regular Pap smears and HPV tests excel at detecting cellular changes early, there are currently no approved products on the US market designed to actively support the local immune system in clearing the virus. The standard medical protocol is "watchful waiting"—monitoring the infection over two years to see if the body clears it on its own. This passive approach can leave women feeling anxious and uncertain about their long-term health.

What is CX-Clear?

CX-Clear (where "CX" stands for cervix) is an investigational vaginal suppository formulated to proactively support and strengthen the local cervical immune response against HPV. It is crafted from natural, food-grade ingredients, combining targeted vitamins, minerals, and botanical extracts.

Study Objective
The goal of this study is to evaluate the efficacy of CX-Clear in supporting the immune system to actively target and accelerate the clearance of high-risk HPV, aiming for clearance within a 3-month timeframe rather than years of uncertain waiting.


Study Details & Participation Requirements

  • Eligibility Criteria:
    • Females aged 18–60 residing in the United States.
    • Currently HPV-positive (documented via lab results).
    • Otherwise in good health (no history of cancer, organ transplants, current pregnancy, or breastfeeding).
  • Study Duration & Protocol:
    • Total commitment: 12 weeks (3 months).
    • Protocol: Insert one CX-Clear suppository twice a week, and insert one Vaginal Probiotic capsule on alternating days between suppository applications.
  • Participant Tracking:
    • Briefly document daily symptom changes in a provided journal utilizing a simplified tracking template.
  • Participation Cost:
    • A fully refundable $120 deposit is required to secure enrollment and ensure study completion.
    • This deposit covers your physical study materials: 3 packs of CX-Clear suppositories and 1 bottle (60 capsules) of Vaginal Probiotics.
    • Full Refund: Upon completing the 12-week protocol, submitting your tracking journal, and providing a follow-up HPV lab test from your original testing facility, your $120 deposit will be refunded in full, bringing your net product cost to zero.
  • Benefits of Joining:
    • An opportunity to actively address a persistent HPV infection at no product cost.
    • If your infection is not cleared during the initial round, you will be eligible to participate in additional study rounds completely free of charge until clearance is achieved.
    • Your participation directly contributes to the development of natural, evidence-based alternatives in women's health and wellness.

How to Sign Up

We are currently accepting exactly 10 volunteers for this initial cohort on a strict first-come, first-served basis.
If you meet the eligibility criteria and would like to secure your place in this evaluation, please email us directly at help@neueve.com.

Jul 31, 2026

Not finding what you're looking for? Contact Us Directly